Global Artificial Intelligence (AI) in Drug Discovery Market Overview:
Global Artificial Intelligence (AI) in Drug Discovery Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Artificial Intelligence (AI) in Drug Discovery Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Artificial Intelligence (AI) in Drug Discovery involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Intelligence (AI) in Drug Discovery Market:
The Artificial Intelligence (AI) in Drug Discovery Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artificial Intelligence (AI) in Drug Discovery Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Intelligence (AI) in Drug Discovery Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artificial Intelligence (AI) in Drug Discovery market has been segmented into:
Oncology
Neurodegenerative Diseases
Metabolic Diseases
Cardiovascular Disease
Infectious Disease
Other Therapeutic Areas
By Application, Artificial Intelligence (AI) in Drug Discovery market has been segmented into:
Drug Optimization & Repurposing
Preclinical Testing
Other Applications).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Intelligence (AI) in Drug Discovery market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Intelligence (AI) in Drug Discovery market.
Top Key Players Covered in Artificial Intelligence (AI) in Drug Discovery market are:
Atomwiseinc
Benevolentai
Berg LLC
Bioage
Cloud Pharmaceuticalsinc
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google (A Subsidiary of Alphabet Inc.)
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numediiinc
Numerate
NVIDIA Corporation
Owkininc
Twoxar Incorporated
Verge Genomics
Xtalpiinc
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Artificial Intelligence (AI) in Drug Discovery Market Type
4.1 Artificial Intelligence (AI) in Drug Discovery Market Snapshot and Growth Engine
4.2 Artificial Intelligence (AI) in Drug Discovery Market Overview
4.3 Oncology
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Oncology: Geographic Segmentation Analysis
4.4 Neurodegenerative Diseases
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Neurodegenerative Diseases: Geographic Segmentation Analysis
4.5 Metabolic Diseases
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Metabolic Diseases: Geographic Segmentation Analysis
4.6 Cardiovascular Disease
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Cardiovascular Disease: Geographic Segmentation Analysis
4.7 Infectious Disease
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Infectious Disease: Geographic Segmentation Analysis
4.8 Other Therapeutic Areas
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Other Therapeutic Areas: Geographic Segmentation Analysis
Chapter 5: Artificial Intelligence (AI) in Drug Discovery Market Application
5.1 Artificial Intelligence (AI) in Drug Discovery Market Snapshot and Growth Engine
5.2 Artificial Intelligence (AI) in Drug Discovery Market Overview
5.3 Drug Optimization & Repurposing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Drug Optimization & Repurposing: Geographic Segmentation Analysis
5.4 Preclinical Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Preclinical Testing: Geographic Segmentation Analysis
5.5 Other Applications).
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Other Applications).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artificial Intelligence (AI) in Drug Discovery Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ATOMWISEINC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 BENEVOLENTAI
6.4 BERG LLC
6.5 BIOAGE
6.6 CLOUD PHARMACEUTICALSINC
6.7 CYCLICA
6.8 DEEP GENOMICS
6.9 ENVISAGENICS
6.10 EXSCIENTIA
6.11 GOOGLE (A SUBSIDIARY OF ALPHABET INC.)
6.12 IBM CORPORATION
6.13 INSILICO MEDICINE
6.14 MICROSOFT CORPORATION
6.15 NUMEDIIINC
6.16 NUMERATE
6.17 NVIDIA CORPORATION
6.18 OWKININC
6.19 TWOXAR
6.20 INCORPORATED
6.21 VERGE GENOMICS
6.22 XTALPIINC
Chapter 7: Global Artificial Intelligence (AI) in Drug Discovery Market By Region
7.1 Overview
7.2. North America Artificial Intelligence (AI) in Drug Discovery Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Oncology
7.2.2.2 Neurodegenerative Diseases
7.2.2.3 Metabolic Diseases
7.2.2.4 Cardiovascular Disease
7.2.2.5 Infectious Disease
7.2.2.6 Other Therapeutic Areas
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Drug Optimization & Repurposing
7.2.3.2 Preclinical Testing
7.2.3.3 Other Applications).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Artificial Intelligence (AI) in Drug Discovery Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Oncology
7.3.2.2 Neurodegenerative Diseases
7.3.2.3 Metabolic Diseases
7.3.2.4 Cardiovascular Disease
7.3.2.5 Infectious Disease
7.3.2.6 Other Therapeutic Areas
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Drug Optimization & Repurposing
7.3.3.2 Preclinical Testing
7.3.3.3 Other Applications).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Artificial Intelligence (AI) in Drug Discovery Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Oncology
7.4.2.2 Neurodegenerative Diseases
7.4.2.3 Metabolic Diseases
7.4.2.4 Cardiovascular Disease
7.4.2.5 Infectious Disease
7.4.2.6 Other Therapeutic Areas
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Drug Optimization & Repurposing
7.4.3.2 Preclinical Testing
7.4.3.3 Other Applications).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Oncology
7.5.2.2 Neurodegenerative Diseases
7.5.2.3 Metabolic Diseases
7.5.2.4 Cardiovascular Disease
7.5.2.5 Infectious Disease
7.5.2.6 Other Therapeutic Areas
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Drug Optimization & Repurposing
7.5.3.2 Preclinical Testing
7.5.3.3 Other Applications).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Oncology
7.6.2.2 Neurodegenerative Diseases
7.6.2.3 Metabolic Diseases
7.6.2.4 Cardiovascular Disease
7.6.2.5 Infectious Disease
7.6.2.6 Other Therapeutic Areas
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Drug Optimization & Repurposing
7.6.3.2 Preclinical Testing
7.6.3.3 Other Applications).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Artificial Intelligence (AI) in Drug Discovery Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Oncology
7.7.2.2 Neurodegenerative Diseases
7.7.2.3 Metabolic Diseases
7.7.2.4 Cardiovascular Disease
7.7.2.5 Infectious Disease
7.7.2.6 Other Therapeutic Areas
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Drug Optimization & Repurposing
7.7.3.2 Preclinical Testing
7.7.3.3 Other Applications).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artificial Intelligence (AI) in Drug Discovery Scope:
|
Report Data
|
Artificial Intelligence (AI) in Drug Discovery Market
|
|
Artificial Intelligence (AI) in Drug Discovery Market Size in 2025
|
USD XX million
|
|
Artificial Intelligence (AI) in Drug Discovery CAGR 2025 - 2032
|
XX%
|
|
Artificial Intelligence (AI) in Drug Discovery Base Year
|
2024
|
|
Artificial Intelligence (AI) in Drug Discovery Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Atomwiseinc, Benevolentai, Berg LLC, Bioage, Cloud Pharmaceuticalsinc, Cyclica, Deep Genomics, Envisagenics, Exscientia, Google (A Subsidiary of Alphabet Inc.), IBM Corporation, Insilico Medicine, Microsoft Corporation, Numediiinc, Numerate, NVIDIA Corporation, Owkininc, Twoxar Incorporated, Verge Genomics, Xtalpiinc.
|
|
Key Segments
|
By Type
Oncology
Neurodegenerative Diseases
Metabolic Diseases
Cardiovascular Disease
Infectious Disease
Other Therapeutic Areas
By Applications
Drug Optimization & Repurposing
Preclinical Testing
Other Applications).
|
